IRDiRC, a global collaborative initiative with the vision to enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention, today announced the formation of the Regulatory Science Committee (RSC).
The recently signed strategic partnership between ECRIN and EUPATI, has been taken to the next level by the election of Christine Kubiak, ECRIN’s Operations Director, as Board member at EUPATI.
On 15 & 16 of September the consortium member of the canSERV project met in Brussels in a meeting organised by the CanSERV coordinator, BBMRI, to launch the new ambitious project that aims to develop a unified provision of transnational services in the field of cancer research.
On the 13th and 14th of July 2022, over 70 participants from the Eastern Africa region met to discuss Personalised Medicine (PM) and identify regional specific needs around the area of PM for potential collaboration between and across African Sub Regions and Europe.
The TTV Guide-IT clinical trial received approval through the Clinical Trial Information System in July. This marks one of the first multinational academic clinical trial that requested approval directly in the new system and did not migrate from VHP (Voluntary Harmonization Procedure).
This year EULAC PerMed organises the 2022 edition of its Summer School and Technical Workshop in Panama City (Panama).
ECRIN, together with our German national partner, the KKS Netzwerk, hosted International Clinical Trials Day 2022 as a hybrid event located in Berlin.
We are very proud to present to you the ECRIN Annual Report 2021! As you may notice right away, the Annual Report is presented to you in an entirely new format. Namely, the size changed from an A4 to a square format, so that it will better fit your screens.
In June 2022, after 42 months of extensive work from the 11 consortium partners, SYNCHROS (SYNergies for Cohorts in Health: integrating the Role of all Stakeholders) is coming to an end.
On June 16th and 17th the PERMIT project consortium, personalised medicine experts and other invested stakeholders met in Milan (and online) at the Istituto di Recherche Farmacologiche Mario Negri to discuss the recommendations that were developed over the 2.5 years of the project.
The SIMCor project is developing a computational platform for in-silico testing and validation of cardiovascular implantable devices. How this works?
The call for application to ECRIN Data Centre Certification Programme is open until the 23 September 2022.
ECRIN and its national partners are working on a training series that will focus on supporting researchers to develop proposals for European calls that are open to mult
ISIDORe just launched the first call for transnational access for projects focusing on SARS-CoV-2 and COVID-19 research. ISIDORe TNA programme aims at supporting scientists by providing them access (physical, remote, or virtual) to facilities, equipment, expertise, services and resources that the
TRANSVAC2, an European vaccine research and development (R&D) infrastructure project, is dedicated to accelerating the development of safe, effective and affordable vaccines.
ECRIN supports clinical trials across borders. How do we do that? We are very proud to show it to you in our brand new video!
The EU-SolidAct trial, previously authorized under the EU CT Directive 2001/20/EC, has been successfully transferred and is authorized under the new EU regulation (Regulation (EU) No 536/2014) in 12 countries.
After more than 2 years, our partner EUPATI organises the Fundamentals in a face to face session. EUPATI Fundamentals is a training about Patient Engagement addressed to professionals in academia and pharmaceutical industry.
